Tags

Type your tag names separated by a space and hit enter

CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis

Publisher

Canadian Agency for Drugs and Technologies in Health
Ottawa (ON)

Language

eng

PubMed ID

31206289

Citation

CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis. Canadian Agency for Drugs and Technologies in Health, 2019, Ottawa (ON).
CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019.
(2019). In CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health;
CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019.
* Article titles in AMA citation format should be in sentence-case
TY - BOOK T1 - CADTH Canadian Drug Expert Committee Recommendation: Edaravone (Radicava — Mitsubishi Tanabe Pharma Corporation): Indication: For the treatment of amyotrophic lateral sclerosis Y1 - 2019/03// PY - 2019/6/18/pubmed PY - 2019/6/18/medline PY - 2019/6/18/entrez PB - Canadian Agency for Drugs and Technologies in Health CY - Ottawa (ON) UR - https://www.unboundmedicine.com/medline/citation/31206289/CADTH_Canadian_Drug_Expert_Committee_Recommendation:_Edaravone_(Radicava_—_Mitsubishi_Tanabe_Pharma_Corporation):_Indication:_For_the_treatment_of_amyotrophic_lateral_sclerosis L2 - https://www.ncbi.nlm.nih.gov/books/NBK542405 DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows